Product Information
ROBAFEN CF LIQUID is a generic product labeled by Major Pharmaceuticals, priced at $0.0209 per ML under NDC 00904653720. Its NADAC has been published 554 times since Feb 24, 2016.
Strength
20; 200; 10 mg/10mL; mg/10mL; mg/10mL
Manufacturer
Major PharmaceuticalsNDC
00904653720
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
11/30/2015
Pharmacological Classes
Price Statistics
The NADAC for ROBAFEN CF LIQUID has been published 554 times since Feb 24, 2016, and over the history we have for it it has risen 19.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0209 per ML |
|---|---|
| All-time high | $0.0222 (Oct 14, 2020) |
| All-time low | $0.0138 (Mar 17, 2021) |
| 52-week high | $0.0210 |
| 52-week low | $0.0193 |
| Median price | $0.0180 |
| Average price | $0.0181 |
| Largest weekly change | +29.3% (Aug 23, 2023) |
| Weeks tracked | 554 |
| Tracking since | Feb 24, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, Guaifenesin, Phenylephrine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin, Phenylephrine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROBAFEN CF LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for ROBAFEN CF LIQUID, manufactured by Major Pharmaceuticals, is $0.0209 per ML (NDC 00904653720), effective Sep 30, 2026.
How has the price of ROBAFEN CF LIQUID changed over time?
Over the history we have for it, the NADAC for ROBAFEN CF LIQUID has risen 19.8%. It has been tracked across 554 weekly CMS publications since Feb 24, 2016.
What are the highest and lowest recorded NADAC prices for ROBAFEN CF LIQUID?
Since Feb 24, 2016, the NADAC for ROBAFEN CF LIQUID has ranged from a low of $0.0138 (Mar 17, 2021) to a high of $0.0222 (Oct 14, 2020), with a median of $0.0180 per ML.
Are there cheaper alternatives to ROBAFEN CF LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of ROBAFEN CF LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROBAFEN CF LIQUID?
ROBAFEN CF LIQUID (NDC 00904653720) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.